Needle Free Drug Delivery Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Needle Free Drug Delivery Market: By Technology (Jet injectors, Inhaler Technology, Novel Needle Free Technologies, and Transdermal Patch Technology), By Site of Delivery (Intra Dermal Injectors, Intramuscular Injectors, and Subcutaneous Injectors), By Applications (Pain Management, Insulin Delivery, Vaccine Delivery, and Others), By Distribution Channel (Hospitals, Clinics, and Others), and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global Needle Free Drug Delivery Market size was valued at USD 7.41 billion in 2020. It is poised to exhibit a CAGR of 10.6% during the forecast period 2021-2027. Needle Free Drug Delivery Market is the medical devices that deliver the drug through the skin using the forces such as shock waves, pressurized gas or electrophoresis and by Lorentz which propels the drug through the skin which virtually nullify the use of the hypodermic needles. Large number of the patients opting for self-administration of drugs which would be possible using the needle free drug delivery devices. The adoption of the needle free drug delivery devices helps in reducing the healthcare expenses to the patients. In recent years, needle-free injection technologies, such as injection systems that deliver medications subcutaneously without piercing the skin with a needle, have gained popularity around the world. Needle anxiety, injection-related pain, needlestick injuries, and infection and/or disease transfer have all been reduced using needle-free injection devices. Over the last few decades, huge strides have been achieved in the development of safe, effective, and convenient medication administration methods. The latest generation of needle-free drug delivery systems reduces the incidence of needle stick injuries among healthcare workers and prevents syringe and needle misuse. Needles-free technology has the obvious advantage of successful drug delivery for a wide range of medications and is bio-equivalent to a syringe and needle, resulting in less pain, and it is strongly preferred by patients. In comparison to conventional needles, the injection is much faster, and there are no needle disposal difficulties. Not only may it help the pharmaceutical sector enhance product sales, but it also has the potential to improve dose regimen compliance and outcomes. A portal device, on the other hand, injects a quick, high-pressure stream of medicine into the skin in programmable amounts, as thin as a strand of hair.


Global Needle Free Drug Delivery Market

MARKET SUMMARY
-
10.6%
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 10.6%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Needle Free Drug Delivery Market

  • Needle free drug delivery market is segmented based on the technology, site of delivery, applications, and distribution channel.
  • Needle Free Drug Delivery Market gives historical, current, and future market sizes (US$ Bn) of product type and distribution channel and geographic regions.
  • This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • In addition, the market report includes regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
  • Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
  • Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of Infant nutrition.
  • In February 2017, PharmaJet and Genexine collaborate on DNA vaccine development and commercialization of DNA vaccines for human applications using the PharmaJet needle-free injection systems
Market Key Players
  • Inovio Pharmaceuticals
  • 3M Pharmaceuticals
  • Antares Pharma,
  • Crossject SA (France)
  • Becton Dickinson and Company
  • MedImmune, Inc.
  • Optinose, Inc.
  • PharmaJet
Growth

Needle Free Drug Delivery Market

Increase in the prevalence of chronic diseases such as hepatitis B, hepatitis C, AIDS etc. which drives the extensive use of injections and in turn helps in the needle free drug delivery market revenue growth. The growing necessity of self-administration and a significant growth of the geriatric population adding fuel for the growth of the needle free drug delivery market. The ease of administration and pain-free drug delivery and increasing focus on the portable delivery devices has boosted the market growth. However, the restricted use of the needle-free injection systems may hamper the growth of the needle free drug delivery market.


North-America Got Significant Share

Needle Free Drug Delivery Market

Geographically, global needle free drug delivery market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America needle free drug delivery market is accounted for significant owing to increase in the prevalence of chronic disorders. The adoption of the modern treatments is anticipated to drive the growth of the free drug delivery market. The Asia Pacific is expected to grow faster rate over the forecast period owing to the growing prevalence of chronic diseases and favorable patient demographics.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015 to 2020) and forecast (2021 to 2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Needle Free Drug Delivery Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Inovio Pharmaceuticals, Inc.(U.S)
  • 3M Pharmaceuticals (U.S)
  • Antares Pharma, Inc. (U.S)
  • Crossject SA (France)
  • Becton Dickinson and Company (U.S)
  • MedImmune, Inc. (U.S)
  • Optinose, Inc. (U.S)
  • PharmaJet (U.S)

Description

The global Needle Free Drug Delivery Market size was valued at USD 7.41 billion in 2020. It is poised to exhibit a CAGR of 10.6% during the forecast period 2021-2027. Needle Free Drug Delivery Market is the medical devices that deliver the drug through the skin using the forces such as shock waves, pressurized gas or electrophoresis and by Lorentz which propels the drug through the skin which virtually nullify the use of the hypodermic needles. Large number of the patients opting for self-administration of drugs which would be possible using the needle free drug delivery devices. The adoption of the needle free drug delivery devices helps in reducing the healthcare expenses to the patients. In recent years, needle-free injection technologies, such as injection systems that deliver medications subcutaneously without piercing the skin with a needle, have gained popularity around the world. Needle anxiety, injection-related pain, needlestick injuries, and infection and/or disease transfer have all been reduced using needle-free injection devices. Over the last few decades, huge strides have been achieved in the development of safe, effective, and convenient medication administration methods. The latest generation of needle-free drug delivery systems reduces the incidence of needle stick injuries among healthcare workers and prevents syringe and needle misuse. Needles-free technology has the obvious advantage of successful drug delivery for a wide range of medications and is bio-equivalent to a syringe and needle, resulting in less pain, and it is strongly preferred by patients. In comparison to conventional needles, the injection is much faster, and there are no needle disposal difficulties. Not only may it help the pharmaceutical sector enhance product sales, but it also has the potential to improve dose regimen compliance and outcomes. A portal device, on the other hand, injects a quick, high-pressure stream of medicine into the skin in programmable amounts, as thin as a strand of hair.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX